BNTC — Benitec Biopharma Share News
0.000.00%
- $301.79m
- $121.82m
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:46 AM
Brief: Benitec Biopharma Inc - QTRLY Loss Per Share $0.40
Brief: Benitec Biopharma Discloses Q2 2022 Financial Results
Brief: Benitec Biopharma Reports Q1 2022 Loss Per Share $0.62
NASDAQ RESUMED AT 01:10 PM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 01:06 PM
Brief: Benitec Provides Positive Regulatory Updates For BB-301 Development Program
U.S. STOCKS ON THE MOVE-Benitec Biopharma, Enphase Energy, MicroVision
U.S. STOCKS ON THE MOVE-Alphabet, MicroVision, Benitec Biopharma
U.S. STOCKS ON THE MOVE-Microsoft, Pinterest, AMD
Benitec Biopharma drops on upsized stock deal
Brief: Benitec Biopharma Increases Previously Announced Bought Deal Offering Of Common Stock To $12.9 Million
Brief: Benitec Biopharma Announces $7.5 Million Bought Deal Offering Of Common Stock
Brief: Steven M. Oliveira Reports A Passive Stake Of 8.20% In Benitec Biopharma As Of April 1, 2021
Benitec Biopharma: More than doubles after Morgan Stanley reveals stake
Brief: Benitec Biopharma Announces Successful Results From The Interim Analysis Of The BB-301 Pilot Dosing Study
Brief: Benitec Biopharma Files For Mixed Shelf Of Upto $75 Mln
Brief: Alpha Capital Anstalt Reports 9.2% Passive Stake In Benitec Biopharma
U.S. STOCKS ON THE MOVE-Academy Sports and Outdoors, Workhorse Group, Telenav, Janus Henderson